Shares of Hexcel Corporation dropped 5.7% to $84.78 after the advanced composites maker posted third-quarter results that disappointed Wall Street on the top line, raising fresh questions about the durability of its recovery narrative in a stock still priced at roughly 38 times forward earnings.

A Revenue Miss Driven by One Stumbling Segment

Net sales of $496.4 million rose 8.8% year-over-year but landed below the $501.9 million analyst consensus. The culprit was clear: commercial aerospace surged 20.5% to $330.3 million, beating estimates, but Defense, Space & Other sales fell 8.7% to $166.1 million, badly missing the $180.1 million forecast. That $14 million defense shortfall single-handedly accounts for the revenue gap. For a company where defense and space still represent about a third of sales, that's a meaningful drag investors can't ignore.

Divestitures Explain Part of the Drop — But Not All of It

The decline "primarily reflected" Hexcel's 2025 sale of an Austrian industrial unit and the closure of a UK facility, but management also cited "temporary softness in F-35 and an international fighter program as well as launchers and rocket motors." Divestitures are known headwinds; slipping fighter and space programs are not. Adjusted operating income of $54.4 million also missed the $61 million consensus , and gross margin of 23.3% fell short of the expected 24.6% , signaling that higher costs from accelerated hiring and training to meet anticipated demand are eating into profitability now.

Guidance Held Steady — A Signal of Confidence or Caution?

Hexcel maintained its 2026 sales guidance of $2.025–$2.125 billion and adjusted EPS of $2.30–$2.40. With nine-month sales at $1.527 billion, the company needs roughly $498–$598 million in Q4 — a wide range that leaves room for a soft landing but little cushion if defense weakness persists. The board also boosted its share buyback authorization to $750 million , a move designed to reassure investors the balance sheet is healthy.

A Valuation That Demands Execution

Analysts maintain a consensus Buy with a $104.47 mean price target, though only 6 of 17 analysts rate it Buy versus 11 at Hold. At $84.78, the stock sits 24% below its 52-week high. The bull case — widebody production ramping at Airbus and Boeing — remains intact, but Q3 proves the market won't forgive stumbles at this price-to-earnings level when a third of the business is shrinking.